Yuan M - Search Results

1

Efficacy and safety of dual blockade of HER2 and PD-1 in patients with HER2-positive gastric cancer: a retrospective, multicentre study.

Cen S, Yuan M, Sun Q, Hou G, Ying J, Xu Q, Zheng Y, Dong Y, Pan H, Han W. Cen S, et al. Among authors: yuan m. Sci Rep. 2024 Oct 23;14(1):25030. doi: 10.1038/s41598-024-76296-y. Sci Rep. 2024. PMID: 39443515 Free PMC article.

2

Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinoma.

Pan H, Cheng H, Wang H, Ge W, Yuan M, Jiang S, Wan X, Dong Y, Liu Z, Zhao R, Fang Y, Lou F, Cao S, Han W. Pan H, et al. Among authors: yuan m. Cancer Sci. 2021 Nov;112(11):4758-4771. doi: 10.1111/cas.15119. Epub 2021 Sep 12. Cancer Sci. 2021. PMID: 34449929 Free PMC article.

3

The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy.

Yuan M, Wang Z, Lv W, Pan H. Yuan M, et al. Front Mol Biosci. 2022 Mar 30;9:870395. doi: 10.3389/fmolb.2022.870395. eCollection 2022. Front Mol Biosci. 2022. PMID: 35433839 Free PMC article. Review.

4

Progress of PD-1/PD-L1 inhibitor combination therapy in immune treatment for HER2-positive tumors.

Zhao S, Qiu Y, Yuan M, Wang Z. Zhao S, et al. Among authors: yuan m. Eur J Clin Pharmacol. 2024 May;80(5):625-638. doi: 10.1007/s00228-024-03644-2. Epub 2024 Feb 11. Eur J Clin Pharmacol. 2024. PMID: 38342825 Review.

5

Activation of the PERK-ATF4 pathway promotes chemo-resistance in colon cancer cells.

Shi Z, Yu X, Yuan M, Lv W, Feng T, Bai R, Zhong H. Shi Z, et al. Among authors: yuan m. Sci Rep. 2019 Mar 1;9(1):3210. doi: 10.1038/s41598-019-39547-x. Sci Rep. 2019. PMID: 30824833 Free PMC article.

6

The significance of multi-line chemotherapy for advanced gastric cancer: A retrospective analysis.

Yuan M, Shi Z, Wang Z, Lv W, Yang Y, Lu F, Zhao Y, Zhong H. Yuan M, et al. Mol Clin Oncol. 2017 Apr;6(4):606-612. doi: 10.3892/mco.2017.1163. Epub 2017 Feb 10. Mol Clin Oncol. 2017. PMID: 28413678 Free PMC article.

7

Paclitaxel combined with capecitabine as first-line chemotherapy for advanced or recurrent gastric cancer.

Yuan M, Yang Y, Lv W, Song Z, Zhong H. Yuan M, et al. Oncol Lett. 2014 Jul;8(1):351-354. doi: 10.3892/ol.2014.2131. Epub 2014 May 9. Oncol Lett. 2014. PMID: 24959275 Free PMC article.

8

Serum alkaline phosphatase predicts survival outcomes in patients with skeletal metastatic nasopharyngeal carcinoma.

Jin Y, Yuan MQ, Chen JQ, Zhang YP. Jin Y, et al. Clinics (Sao Paulo). 2015 Apr;70(4):264-72. doi: 10.6061/clinics/2015(04)08. Clinics (Sao Paulo). 2015. PMID: 26017793 Free PMC article.

9

A retrospective analysis of hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.

Yuan M, Wang Z, Hu G, Yang Y, Lv W, Lu F, Zhong H. Yuan M, et al. Mol Clin Oncol. 2016 Aug;5(2):395-399. doi: 10.3892/mco.2016.918. Epub 2016 Jun 2. Mol Clin Oncol. 2016. PMID: 27446587 Free PMC article.

10

Cetuximab Can Be an Effective and Low-Toxicity Maintenance Treatment Drug in Patients With Metastatic Colorectal Cancer: A Real-World Study of Zhejiang Cancer Hospital.

Yuan M, Wang Z, Zhao Y, Feng T, Lv W, Zhong H. Yuan M, et al. Front Pharmacol. 2021 May 28;12:632076. doi: 10.3389/fphar.2021.632076. eCollection 2021. Front Pharmacol. 2021. PMID: 34122063 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,302 results

Search Page

Filters